Bai Ye
Keine laufenden Positionen mehr
Karriereverlauf von Bai Ye
Ehemalige bekannte Positionen von Bai Ye
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Huarong International Trust Co., Ltd.
 Huarong International Trust Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Part of China Trust Protection Fund Co. Ltd., Huarong International Trust Co., Ltd. is a Chinese company that provides trust services. The company is based in Beijing, China. The company was founded in 2008. The CEO is Yi Ming Shen. Huarong International Trust Co. was acquired by China Trust Protection Fund Co. Ltd. from China Huarong Asset Management Co., Ltd. on December 29, 2022 for $909.69 million. | Corporate Officer/Principal | - | - |
| Hebei Huari Pharmaceutical Co. Ltd. | Corporate Officer/Principal | - | - |
| CHINA CITIC FINANCIAL ASSET MANAGEMENT CO., LTD. | Corporate Officer/Principal | 01.01.2007 | - |
| Vertrieb & Marketing | - | - | |
| HUARONG INTERNATIONAL FINANCIAL HOLDINGS LIMITED | Corporate Officer/Principal | 08.12.2017 | - |
Statistik
International
| China | 4 |
| Hong Kong | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Sales & Marketing | 1 |
Sektoral
| Finance | 3 |
| Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HUARONG INTERNATIONAL FINANCIAL HOLDINGS LIMITED | Finance |
| CHINA CITIC FINANCIAL ASSET MANAGEMENT CO., LTD. | Finance |
| Private Unternehmen | 2 |
|---|---|
Huarong International Trust Co., Ltd.
Huarong International Trust Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Part of China Trust Protection Fund Co. Ltd., Huarong International Trust Co., Ltd. is a Chinese company that provides trust services. The company is based in Beijing, China. The company was founded in 2008. The CEO is Yi Ming Shen. Huarong International Trust Co. was acquired by China Trust Protection Fund Co. Ltd. from China Huarong Asset Management Co., Ltd. on December 29, 2022 for $909.69 million. | Miscellaneous |
| Hebei Huari Pharmaceutical Co. Ltd. |
